UPSA

France upsa.com

French pharmaceutical company founded in 1935, specializing in OTC medicines, medical devices and dietary supplements. Leading French manufacturer of paracetamol-based products with main production site in Agen. Partner with SEQENS (and Sanofi/Opella) for reshoring paracetamol API production in France.

Also known as Union de Pharmacologie Scientifique Appliquée.

Projects UPSA is involved in

chemXplore tracks 1 project involving UPSA, of which one is active.

UPSA's role on them: Offtaker.

1 Under Construction

1 new construction.

Expected to start operating

2026: none
2027: 1 project
2028: none
2029: none
2030: none
2031: none

Contractors, licensors, and offtakers are recorded on this project For subscribers

Targeting: Paracetamol (1)

Follow this project in chemXplore →

Latest news on UPSA

15 December 2025

SEQENS advances paracetamol production unit at Roussillon

Continuous-flow, lower-footprint paracetamol process; 15,000 t/yr from end‑2026; backed by France 2030 with UPSA and Opella as partners.

29 July 2021

SEQENS to Build New Paracetamol Unit in Roussillon, France

The new unit, supported by France Relance, will produce 10,000 tonnes of paracetamol annually by 2023, using innovative, eco-friendly processes to meet growing demand and enhance EU health sovereignty.

Where its projects are

By country, the most active first. active / all projects

France 1 active project, 1 in all